KMT2A and leukemia: Similar to our observations in MLL-AF9-driven leukemia cells, we did not observe a proliferation advantage in the absence of STAT3β in MLL-ENL or NUP98-HOXD13-driven leukemia cells (Supplementary Fig. 2D).